SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-026051
Filing Date
2022-11-04
Accepted
2022-11-04 16:30:21
Documents
16
Period of Report
2022-11-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pirs20221103_8k.htm   iXBRL 8-K 33993
2 EXHIBIT 1.1 ex_442809.htm EX-1.1 25635
3 EXHIBIT 5.1 ex_442673.htm EX-5.1 13335
8 logobrwn.jpg GRAPHIC 3596
  Complete submission text file 0001437749-22-026051.txt   226149

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pirs-20221104.xsd EX-101.SCH 3601
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20221104_def.xml EX-101.DEF 11919
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20221104_lab.xml EX-101.LAB 15966
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20221104_pre.xml EX-101.PRE 12130
10 EXTRACTED XBRL INSTANCE DOCUMENT pirs20221103_8k_htm.xml XML 2650
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 221362704
SIC: 2834 Pharmaceutical Preparations